LABORATORIOS FARMACEUTICOS ROVI, S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 82.7 EUR | -2.71% |
|
+4.09% | +37.38% |
| 02/04 | Spain's Rovi Obtains US FDA Approval for Marketing Risvan as Schizophrenia Treatment | MT |
| 12/03 | Rovi, Partners to Form Entity for Advanced Therapies R&D | MT |
Business Summary
- pharmaceutical products manufactured under contract (49%);
- prescription pharmaceuticals (45%): intended for preventing and treating venous thrombo-embolic disease, post-menopausal osteoporosis, muscle pain, tooth and mouth infections, angina, osteoarthritis, etc.;
- diagnostic products (6%): contrast products used in medical imaging with magnetic resonance, ultrasound, or X-rays. The group also offers hospital products and non-prescription pharmaceuticals.
Net sales break down by source of revenue between sales of products (50.6%), sales of services (49.3%) and sales of licenses (0.1%).
Net sales are distributed geographically as follows: Spain (33%), European Union (17.3%), OECD countries (45.9%) and other (3.8%).
Number of employees: 1,925
Sales per Business
| EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Marketing
50.7
%
| 414 | 50.6 % | 420 | 50.7 % | +1.47% |
Manufacturing
49.3
%
| 404 | 49.4 % | 409 | 49.3 % | +1.42% |
Sales per region
| EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Organisation for Economic Co-operation and Development
45.9
%
| 377 | 46.1 % | 381 | 45.9 % | +1.09% |
Spain
33.0
%
| 264 | 32.3 % | 273 | 33.0 % | +3.44% |
European Union
17.3
%
| 137 | 16.7 % | 144 | 17.3 % | +5.20% |
Rest
3.8
%
| 40 | 4.9 % | 32 | 3.8 % | -21.18% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 01/94/01 | |
| Director of Finance/CFO | - | 01/00/01 | |
| Chief Tech/Sci/R&D Officer | - | - | |
| Director/Board Member | - | 01/95/01 | |
| Investor Relations Contact | - | 01/08/01 | |
| Sales & Marketing | - | 01/16/01 | |
| Sales & Marketing | - | - | |
| General Counsel | - | 01/07/01 | |
| Corporate Officer/Principal | - | - | |
| Comptroller/Controller/Auditor | - | 01/21/01 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 01/95/01 | |
| Director of Finance/CFO | - | 01/00/01 | |
| Chief Executive Officer | - | 01/94/01 | |
| Director/Board Member | 57 | 01/19/01 | |
| Director/Board Member | - | 09/19/09 | |
| Director/Board Member | - | 10/22/10 | |
| Director/Board Member | - | 14/22/14 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 54,016,157 | 19,274,107 ( 35.68 %) | 2,196,011 ( 4.065 %) | 35.68 % |
Holdings
| Name | Equities | % | Valuation |
|---|---|---|---|
| 2,659,984 | 4.92% | 232,408,122 $ |
Company contact information
Laboratorios Farmaceúticos Rovi SA
Calle José Isbert, 2 Pozuelo de Alarcón
28223, Madrid
+34 91 021 30 00
http://www.rovi.es
Group companies
| Name | Category and Sector |
|---|---|
Frosst Ibérica SA
 Frosst Ibérica SA Pharmaceuticals: MajorHealth Technology Part of Norbel Inversiones SL, Frosst Ibérica SA is a leading pharmaceutical CMO. Our injectable and solid form products are manufactured in the metropolitan area in Alcala de Henares, Spain. We provide reliable aseptic filling for patients and are known for our expertise, constant dedication, and transparency in the field of contract manufacturing. Frosst Ibérica was acquired by ROVI Imaging SL from Merck & Co., Inc. on July 27, 2009 for $5.11 million. |
Pharmaceuticals: Major
|
Rovi Contract Manufacturing SL
 Rovi Contract Manufacturing SL Pharmaceuticals: MajorHealth Technology Part of Norbel Inversiones SL, Rovi Contract Manufacturing SL is a Spanish company that has been researching and growing in the healthcare industry for 70 years. The private company is located in Spain. The company offers prescription medical products manufactured or marketed by Laboratorios ROVI. The company is the ideal choice for pharmaceutical companies looking to outsource their manufacturing processes. The company also provides products for imaging diagnostics and other hospital products. |
Pharmaceuticals: Major
|
Pan Química Farmacéutica SA
 Pan Química Farmacéutica SA Pharmaceuticals: MajorHealth Technology Part of Norbel Inversiones SL, Pan Química Farmacéutica SA is a Spanish company that manufactures pharmaceutical products. The private company is located in Spain. |
Pharmaceuticals: Major
|
Sector
Sales per Business
Sales per region
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +37.38% | 4.7B | |
| +26.47% | 661B | |
| +26.74% | 566B | |
| -6.33% | 352B | |
| +19.35% | 332B | |
| +4.23% | 283B | |
| +13.43% | 231B | |
| +4.71% | 200B | |
| -9.53% | 195B | |
| -4.04% | 145B |
- Stock Market
- Equities
- ROVI Stock
- Company Laboratorios Farmaceuticos Rovi, S.A.
